Global Human Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
According to APO Research, The global Human Prothrombin Complex market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
Human Prothrombin Complex segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Prothrombin Complex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
According to APO Research, The global Human Prothrombin Complex market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Human Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
Human Prothrombin Complex segment by Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
- Hemophilia B
- Vitamin K Deficiency
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Prothrombin Complex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Human Prothrombin Complex Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Prothrombin Complex Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Prothrombin Complex Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN PROTHROMBIN COMPLEX MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 HUMAN PROTHROMBIN COMPLEX MARKET BY MANUFACTURERS
3.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
3.2 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)
3.3 Global Human Prothrombin Complex Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Prothrombin Complex Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Prothrombin Complex Manufacturers, Product Type & Application
3.7 Global Human Prothrombin Complex Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2023
3.8.3 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
4 HUMAN PROTHROMBIN COMPLEX MARKET BY TYPE
4.1 Human Prothrombin Complex Type Introduction
4.1.1 500 IU/Vial
4.1.2 600 IU/Vial
4.1.3 1000 IU/Vial
4.1.4 Others
4.2 Global Human Prothrombin Complex Sales by Type
4.2.1 Global Human Prothrombin Complex Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Prothrombin Complex Sales by Type (2019-2030)
4.2.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Revenue by Type
4.3.1 Global Human Prothrombin Complex Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Prothrombin Complex Revenue by Type (2019-2030)
4.3.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
5 HUMAN PROTHROMBIN COMPLEX MARKET BY APPLICATION
5.1 Human Prothrombin Complex Application Introduction
5.1.1 Hemophilia B
5.1.2 Vitamin K Deficiency
5.1.3 Others
5.2 Global Human Prothrombin Complex Sales by Application
5.2.1 Global Human Prothrombin Complex Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Prothrombin Complex Sales by Application (2019-2030)
5.2.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Revenue by Application
5.3.1 Global Human Prothrombin Complex Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Prothrombin Complex Revenue by Application (2019-2030)
5.3.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN PROTHROMBIN COMPLEX SALES BY REGION
6.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Prothrombin Complex Sales by Region (2019-2030)
6.2.1 Global Human Prothrombin Complex Sales by Region (2019-2024)
6.2.2 Global Human Prothrombin Complex Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Prothrombin Complex Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Prothrombin Complex Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Prothrombin Complex Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Prothrombin Complex Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN PROTHROMBIN COMPLEX REVENUE BY REGION
7.1 Global Human Prothrombin Complex Revenue by Region
7.1.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)
7.1.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)
7.1.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Prothrombin Complex Revenue (2019-2030)
7.2.2 North America Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Prothrombin Complex Revenue (2019-2030)
7.3.2 Europe Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Prothrombin Complex Revenue (2019-2030)
7.4.2 Asia-Pacific Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Prothrombin Complex Revenue (2019-2030)
7.5.2 LAMEA Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Takeda
8.1.1 Takeda Comapny Information
8.1.2 Takeda Business Overview
8.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Takeda Human Prothrombin Complex Product Portfolio
8.1.5 Takeda Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Human Prothrombin Complex Product Portfolio
8.2.5 CSL Recent Developments
8.3 Grifols
8.3.1 Grifols Comapny Information
8.3.2 Grifols Business Overview
8.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Grifols Human Prothrombin Complex Product Portfolio
8.3.5 Grifols Recent Developments
8.4 Octapharma
8.4.1 Octapharma Comapny Information
8.4.2 Octapharma Business Overview
8.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Octapharma Human Prothrombin Complex Product Portfolio
8.4.5 Octapharma Recent Developments
8.5 Hualan Biological
8.5.1 Hualan Biological Comapny Information
8.5.2 Hualan Biological Business Overview
8.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
8.5.5 Hualan Biological Recent Developments
8.6 Meheco Xinxing Pharma
8.6.1 Meheco Xinxing Pharma Comapny Information
8.6.2 Meheco Xinxing Pharma Business Overview
8.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
8.6.5 Meheco Xinxing Pharma Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Prothrombin Complex Value Chain Analysis
9.1.1 Human Prothrombin Complex Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Prothrombin Complex Production Mode & Process
9.2 Human Prothrombin Complex Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Prothrombin Complex Distributors
9.2.3 Human Prothrombin Complex Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Human Prothrombin Complex Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Prothrombin Complex Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Prothrombin Complex Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN PROTHROMBIN COMPLEX MARKET DYNAMICS
2.1 Human Prothrombin Complex Industry Trends
2.2 Human Prothrombin Complex Industry Drivers
2.3 Human Prothrombin Complex Industry Opportunities and Challenges
2.4 Human Prothrombin Complex Industry Restraints
3 HUMAN PROTHROMBIN COMPLEX MARKET BY MANUFACTURERS
3.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
3.2 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)
3.3 Global Human Prothrombin Complex Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Prothrombin Complex Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Prothrombin Complex Manufacturers, Product Type & Application
3.7 Global Human Prothrombin Complex Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2023
3.8.3 2023 Human Prothrombin Complex Tier 1, Tier 2, and Tier
4 HUMAN PROTHROMBIN COMPLEX MARKET BY TYPE
4.1 Human Prothrombin Complex Type Introduction
4.1.1 500 IU/Vial
4.1.2 600 IU/Vial
4.1.3 1000 IU/Vial
4.1.4 Others
4.2 Global Human Prothrombin Complex Sales by Type
4.2.1 Global Human Prothrombin Complex Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Prothrombin Complex Sales by Type (2019-2030)
4.2.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Revenue by Type
4.3.1 Global Human Prothrombin Complex Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Prothrombin Complex Revenue by Type (2019-2030)
4.3.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
5 HUMAN PROTHROMBIN COMPLEX MARKET BY APPLICATION
5.1 Human Prothrombin Complex Application Introduction
5.1.1 Hemophilia B
5.1.2 Vitamin K Deficiency
5.1.3 Others
5.2 Global Human Prothrombin Complex Sales by Application
5.2.1 Global Human Prothrombin Complex Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Prothrombin Complex Sales by Application (2019-2030)
5.2.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Revenue by Application
5.3.1 Global Human Prothrombin Complex Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Prothrombin Complex Revenue by Application (2019-2030)
5.3.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN PROTHROMBIN COMPLEX SALES BY REGION
6.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Prothrombin Complex Sales by Region (2019-2030)
6.2.1 Global Human Prothrombin Complex Sales by Region (2019-2024)
6.2.2 Global Human Prothrombin Complex Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Prothrombin Complex Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Prothrombin Complex Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Prothrombin Complex Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Prothrombin Complex Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Prothrombin Complex Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN PROTHROMBIN COMPLEX REVENUE BY REGION
7.1 Global Human Prothrombin Complex Revenue by Region
7.1.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)
7.1.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)
7.1.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Prothrombin Complex Revenue (2019-2030)
7.2.2 North America Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Prothrombin Complex Revenue (2019-2030)
7.3.2 Europe Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Prothrombin Complex Revenue (2019-2030)
7.4.2 Asia-Pacific Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Prothrombin Complex Revenue (2019-2030)
7.5.2 LAMEA Human Prothrombin Complex Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Takeda
8.1.1 Takeda Comapny Information
8.1.2 Takeda Business Overview
8.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Takeda Human Prothrombin Complex Product Portfolio
8.1.5 Takeda Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Human Prothrombin Complex Product Portfolio
8.2.5 CSL Recent Developments
8.3 Grifols
8.3.1 Grifols Comapny Information
8.3.2 Grifols Business Overview
8.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Grifols Human Prothrombin Complex Product Portfolio
8.3.5 Grifols Recent Developments
8.4 Octapharma
8.4.1 Octapharma Comapny Information
8.4.2 Octapharma Business Overview
8.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Octapharma Human Prothrombin Complex Product Portfolio
8.4.5 Octapharma Recent Developments
8.5 Hualan Biological
8.5.1 Hualan Biological Comapny Information
8.5.2 Hualan Biological Business Overview
8.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
8.5.5 Hualan Biological Recent Developments
8.6 Meheco Xinxing Pharma
8.6.1 Meheco Xinxing Pharma Comapny Information
8.6.2 Meheco Xinxing Pharma Business Overview
8.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
8.6.5 Meheco Xinxing Pharma Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Prothrombin Complex Value Chain Analysis
9.1.1 Human Prothrombin Complex Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Prothrombin Complex Production Mode & Process
9.2 Human Prothrombin Complex Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Prothrombin Complex Distributors
9.2.3 Human Prothrombin Complex Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
